DITTO: A Visual Digital Twin for Interventions and Temporal Treatment Outcomes in Head and Neck Cancer

Digital twins can help oncologists weigh complex tradeoffs: DITTO enables Head and Neck Cancer clinicians to analyze personalized risk profiles that account for multiple interacting factors—patient health, tumor location, and toxicity risks—that "cannot be adequately captured through simple heuristics," supporting more informed treatment decisions.

Explainability and visual design are critical for clinical trust: The system incorporates "several visual explainability methods to promote clinical trust and encourage healthy skepticism," reflecting the principle that AI tools in high-stakes medical settings should be transparent rather than treated as black boxes.

Participatory design with end users improves responsible AI deployment: DITTO was developed through "participatory collaborative design alongside oncologists," suggesting that involving actual clinical users in development—rather than building systems in isolation—helps ensure AI tools address real clinical needs and concerns.

Both short-term and long-term outcomes matter for responsible predictions: The system delivers "personalized risk of both long-term and short-term disease outcome and toxicity risk," acknowledging that responsible AI in oncology must consider multiple timeframes and types of harm, not just immediate treatment efficacy.

Clinical validation requires both quantitative and qualitative evaluation: The authors evaluated DITTO through "quantitative evaluation of performance and case studies with qualitative feedback," demonstrating that responsible AI assessment in healthcare should combine statistical metrics with real-world clinical insights.